An RMST-based analysis of systemic therapy in muscle-invasive bladder cancer
Our RMST-based analysis highlights the minimal real-world survival benefits and provides more intuitive and clinically relevant interpretations than traditional hazard ratios. Our visualization framework offers an intuitive approach to assist clinicians and patients in making informed decisions.
Authors
- K.C. Balaji (ORCID: https://orcid.org/0000-0002-8057-2839)
- Nicole Murray (ORCID: https://orcid.org/0000-0001-8381-092X)
- Yudai Ishiyama (ORCID: https://orcid.org/0000-0002-8440-6264)
- Sara D. Sparks (ORCID: https://orcid.org/0000-0002-3110-7084)
- Arjun K. Venkatesh (ORCID: https://orcid.org/0000-0002-8248-0567)
- Mark Bandyk (ORCID: https://orcid.org/0000-0002-3940-3275)
- Mohammed Al-Toubat
- Rebecca Rosales
- Jean-Pierre Kanumuambidi
- Hunter Sceats
Institutions
- St. George's University (GD)
- University of Utah (US)
- University of Florida (US)
- Florida College (US)
Publication Details
- Journal
- Urologic Oncology Seminars and Original Investigations
- Published
- 2025-08-05
- DOI
- https://doi.org/10.1016/j.urolonc.2025.07.002
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00